MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 109 filers reported holding MIRUM PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $66,783,724 | +27.1% | 2,113,409 | +4.1% | 0.00% | +100.0% |
Q2 2023 | $52,525,802 | +27.9% | 2,030,375 | +18.7% | 0.00% | 0.0% |
Q1 2023 | $41,070,020 | -1.4% | 1,709,826 | -20.0% | 0.00% | 0.0% |
Q4 2022 | $41,665,204 | +13.4% | 2,136,677 | +22.1% | 0.00% | 0.0% |
Q3 2022 | $36,754,000 | +35.3% | 1,749,349 | +25.3% | 0.00% | 0.0% |
Q2 2022 | $27,166,000 | +57.6% | 1,396,012 | +78.3% | 0.00% | – |
Q1 2022 | $17,238,000 | +40.0% | 782,830 | +1.4% | 0.00% | – |
Q4 2021 | $12,316,000 | +1.3% | 772,098 | +26.5% | 0.00% | – |
Q3 2021 | $12,162,000 | +15.7% | 610,565 | +0.5% | 0.00% | – |
Q2 2021 | $10,508,000 | -30.3% | 607,734 | -20.1% | 0.00% | – |
Q1 2021 | $15,078,000 | +55.6% | 760,839 | +37.1% | 0.00% | – |
Q4 2020 | $9,689,000 | +19.2% | 554,889 | +31.5% | 0.00% | – |
Q3 2020 | $8,131,000 | -1.8% | 421,969 | -0.8% | 0.00% | – |
Q2 2020 | $8,281,000 | +130.5% | 425,538 | +65.7% | 0.00% | – |
Q1 2020 | $3,593,000 | -19.1% | 256,735 | +41.7% | 0.00% | – |
Q4 2019 | $4,442,000 | +1161.9% | 181,169 | +416.8% | 0.00% | – |
Q3 2019 | $352,000 | – | 35,055 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Frazier Life Sciences Management, L.P. | 6,470,392 | $204,464,387 | 13.58% |
NEA Management Company, LLC | 2,186,243 | $69,085,279 | 5.34% |
TANG CAPITAL MANAGEMENT LLC | 1,137,107 | $35,932,581 | 5.07% |
BOONE CAPITAL MANAGEMENT LLC | 389,791 | $12,317,396 | 3.89% |
Highlander Partners, L.P. | 122,980 | $3,886,168 | 3.84% |
BVF INC/IL | 4,370,024 | $138,092,758 | 3.72% |
Prosight Management, LP | 353,508 | $11,170,853 | 3.54% |
Novo Holdings A/S | 1,500,000 | $47,400,000 | 3.50% |
Nicholas Investment Partners, LP | 1,199,366 | $37,899,966 | 2.83% |
Eventide Asset Management | 3,958,579 | $125,091,097 | 2.25% |